doctors will not want to use it.. period end of story. Botox is a nice revenue stream for the docs. think about it the more often pts come in for injections on a cash product, the more the doc makes. Longer lasting products will not get wide dr. acceptance. its all about the $$$$.
the cost of arte is way more then botox, therefore the doctors make more. also there are a number of pts who get botox just once and never come back for a second time. doctors feel they could make alot more money by using arte and charging the price of 4 botox visits. ever here of pt credit card fatigue. arte is a superior product period
I believe that your wrong, many of the early investors in Artes (pre IPO) are plastic surgeons. I went to a meeting at Artes new headquarters a few years ago when they held an open house for investors and the place was full of doctors who had invested a lot of money in the company.
Plastic surgeons are in it for the money period. Botox, Arte, Juvederm, etc... these are all cash bussiness plays. Anyone in the biz knows that dr.s do botox because it keeps the pts coming back early and often. Dr's will be interested in arte because curiosity killed the cat. in the end doctors will use what keeps the revenue stream in tact. I believe you are misguided by investor hype and a want for Arte to do well. It will make money but not much and not for long.